MedTrace Logo

Effectiveness of Preurodynamic With Posturodynamic Levofloxacin on the Incidence of UTI

NCT05219877 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2023-11-13

Study results available
· View outcomes & findings →

Summary

This study aims to compare the effectiveness of preoperative single dose of levofloxacin with postoperative levofloxacin for three days on the incidence of urinary tract infections (UTI) after urodynamic examination.

Conditions

Interventions

DRUG

Pre-urodynamic Levofloxacin

Levofloxacin 500 mg single dosage 1 hour before the urodynamic examination

DRUG

Post-urodynamic Levofloxacin

Administering once daily Levofloxacin 500 mg for 3 days after urodynamic study

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Harrina Erlianti Rahardjo, Professor · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-04
Primary Completion
2022-04-03
Completion
2022-04-13

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05219877 on ClinicalTrials.gov